新的血液分析技术将较高的T细胞与更好的癌症存活率联系起来。 New blood analysis technique links higher T cell counts to better cancer survival rates.

UCL和Francis Crick研究所的研究人员开发了一种新技术,即 " ImmunELENS " ,该技术计算出整个基因组测序中T和B细胞在血液中的比例。 Researchers from UCL and the Francis Crick Institute have developed a new technique, ImmuneLENS, which calculates the proportion of T and B cells in blood from whole genome sequencing. 他们分析了90,000多份样本,发现癌症患者的T细胞比健康个人少,T细胞水平较高,五年内死亡率低47%。 Analyzing over 90,000 samples, they found cancer patients had fewer T cells than healthy individuals, with higher T cell levels linked to a 47% lower death rate over five years. 这一方法可以加强目前的遗传测试,帮助临床医生裁缝治疗。 This method could enhance current genetic tests, aiding clinicians in tailoring treatments.